Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

Moore, EM; Mander, AG; Ames, D; Kotowicz, MA; Carne, Ross; Brodaty, H; Woodward, M; Ellis, KA; Bush, AI; Faux, NG; Watters, David

Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

journal contribution

posted on 2024-06-05, 05:04 authored by EM Moore, AG Mander, D Ames, MA Kotowicz, Ross CarneRoss Carne, H Brodaty, M Woodward, KA Ellis, AI Bush, NG Faux, David WattersDavid Watters

Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

History

Journal

Diabetes care

Volume

37

Pagination

151-151

Location

Alexandria, Va.

Open access

Yes

Link to full text

https://care.diabetesjournals.org/content/diacare/37/6/e151.full.pdf

eISSN

1935-5548

Language

eng

Author URL

http://www.ncbi.nlm.nih.gov/pubmed/24855179

Publication classification

C4 Letter or note

Copyright notice

2014, American Diabetes Association

Issue

6

Publisher

American Diabetes Association

Usage metrics

Keywords

Cognition Disorders Diabetes Mellitus Female Humans Male Metformin 920104 Diabetes 110399 Clinical Sciences not elsewhere classified School of Medicine 119999 Medical and Health Sciences not elsewhere classified

Response to comment on Moore et al. Increased risk of cognitive impairment in patients with diabetes is associated with metformin. Diabetes care 2013;36:2981-2987.

History

Journal

Volume

Pagination

Location

Open access

Link to full text

eISSN

Language

Author URL

Publication classification

Copyright notice

Issue

Publisher

Usage metrics

Categories

Keywords

Licence

Exports